News stories about CAS Medical Systems (NASDAQ:CASM) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CAS Medical Systems earned a news impact score of 0.13 on Accern’s scale. Accern also assigned press coverage about the medical technology company an impact score of 47.1780064871655 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Here are some of the media headlines that may have effected Accern Sentiment Analysis’s analysis:

CAS Medical Systems (CASM) opened at 0.9699 on Tuesday. The company’s 50-day moving average price is $1.14 and its 200-day moving average price is $1.26. CAS Medical Systems has a 12-month low of $0.80 and a 12-month high of $1.94. The stock’s market cap is $26.51 million.

CAS Medical Systems (NASDAQ:CASM) last issued its quarterly earnings data on Tuesday, August 8th. The medical technology company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.07) by $0.02. The company had revenue of $4.57 million during the quarter, compared to the consensus estimate of $5.41 million. On average, equities analysts expect that CAS Medical Systems will post ($0.27) EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This article was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another website, it was stolen and reposted in violation of United States and international trademark and copyright laws. The correct version of this article can be accessed at

About CAS Medical Systems

CAS Medical Systems, Inc is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products for patient care. The Company designs, manufactures and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It operates through Tissue Oximetry Monitoring, which includes sales of its FORE-SIGHT tissue oximeter monitors, sensors and accessories.

Insider Buying and Selling by Quarter for CAS Medical Systems (NASDAQ:CASM)

Receive News & Ratings for CAS Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CAS Medical Systems Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.